Skip to main content
An official website of the United States government

Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities below and streamline your search by using keyword or type of funding.

Please also check the “Other Notices” tab on the NIH Guide for Grants and Contracts to see updates to NIH policies that ensure alignment with the Administration’s priorities.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Highlighted Topics

Topic TitleClose DateProgram Official
Advancing Nanotechnology Research to Improve Diagnosis and Treatment OptionsMarch 10, 2028

Indu Kohaar, Ph.D.

Sidney Fu, M.D.

Advancing Toward a Cure for Acquired NeuropathyApril 6, 2028Rachel Altshuler, Ph.D.
Advancing Mechanism-driven Translational Research of Beneficial and Detrimental Effect of Psilocybin on Cancer and Other Health ConditionsApril 10, 2028Rachel Altshuler, Ph.D.
GLP-1s: Implications for Nutritional Status and Metabolic HealthApril 24, 2028Edward Sauter, M.D., Ph.D.
Unexplained Anemia in Older Persons: Elucidating Etiologies, Improving Diagnoses, and Identifying and Testing Potential Treatment Strategies  May 11, 2028Young Kim, Ph.D.
Enhancing Data Usage and Utility to Advance Biomedical Research  June 24, 2028Wendy Wang, Ph.D.
Research on the Role of Post-Translational Modifications in Human Health and Disease   (Biomarkers) June 26, 2028Nicolas Hodges, Ph.D.
New approach methodologies for dietary supplement and nutrition researchMay 20, 2028Nancy Emenaker, Ph.D., RDN
Food is MedicineJune 3, 2028Young Kim, Ph.D.

Notice of Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Sort descending Program Official
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-25-043 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/07/2028 Edward Sauter, M.D., Ph.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery PAR-25-044 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 01/07/2028 Edward Sauter, M.D., Ph.D.
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies PAR-25-145 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/07/2028 Rachel Altshuler, Ph.D.
NIH Research Project Grant PA-25-301 (Parent R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 01/07/2028 Asad Umar, D.V.M., Ph.D.
NIH Exploratory/Developmental Research Project Grant PA-25-304 (Parent R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 01/08/2028 Marjorie Perloff, M.D.